ConductScience.org, home

Paper907657

Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.

LeRoy AF and 9 others. Biochem Med, 1977. Cited by 235 papers, by iCite.

Cite this record

ConductScience Library. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry. Papers, record 907657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/907657

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry.
PubMed
Journal
Biochem Med
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
235
iCite
Relative citation ratio, by iCite
9.16
iCite
Revised in PubMed
2019-09-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1LeRoy AFA F
2Wehling MLM L
3Sponseller HLH L
4Friauf WSW S
5Solomon RER E
6Dedrick RLR L
7Litterst CLC L
8Gram TET E
9Guarino AMA M
10Becker DAD A

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PlatinumMajor topic
Animals
Cisplatin
Dogs
Humans
Spectrophotometry, Atomic
Tissue Distribution

Source PubMed

Download CSV of topics

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.

PMIDTitleJournalYearIn PapersSource
41379234Benefit of plasma cystatin C for carboplatin individual dosing in a patient with spinal amyotrophy.Cancer Chemother Pharmacol2025https://conductscience.org/library/papers/41379234PubMed
36892677Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer.Cancer Chemother Pharmacol2023https://conductscience.org/library/papers/36892677PubMed
33675184Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.Cancer Med2021https://conductscience.org/library/papers/33675184PubMed
29725440Pharmacokinetics of continuous transarterial infusion of 5-fluorouracil in patients with advanced hepatocellular carcinoma.Oncol Lett2018https://conductscience.org/library/papers/29725440PubMed
27446541Pharmacokinetic analyses of carboplatin in a patient with cancer of the fallopian tubes undergoing hemodialysis: A case report.Biomed Rep2016https://conductscience.org/library/papers/27446541PubMed
27393140Pharmacokinetics of Irinotecan, Oxaliplatin and 5-Fluorouracil During Hepatic Artery Chronomodulated Infusion: A Translational European OPTILIV Study.Clin Pharmacokinet2017https://conductscience.org/library/papers/27393140PubMed
26225053Superselective Intra-arterial Infusion Chemotherapy with Nedaplatin for Oral Cancer: A Pharmacological Study of the Dose Clearance.J Maxillofac Oral Surg2015https://conductscience.org/library/papers/26225053PubMed
23287530Vitamin B6 metabolism influences the intracellular accumulation of cisplatin.Cell Cycle2013https://conductscience.org/library/papers/23287530PubMed
22966334Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis.Oncol Lett2010https://conductscience.org/library/papers/22966334PubMed
20191372Platination of telomeric DNA by cisplatin disrupts recognition by TRF2 and TRF1.J Biol Inorg Chem2010https://conductscience.org/library/papers/20191372PubMed
16683074A phase I and pharmacokinetic study of irofulven and cisplatin administered in a 30-min infusion every two weeks to patients with advanced solid tumors.Invest New Drugs2006https://conductscience.org/library/papers/16683074PubMed
16372828Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.Clin Pharmacokinet2005https://conductscience.org/library/papers/16372828PubMed
16369746Phase I study of cisplatin and irinotecan combined with concurrent hyperfractionated accelerated thoracic radiotherapy for locally advanced non-small cell lung carcinoma.Int J Clin Oncol2005https://conductscience.org/library/papers/16369746PubMed
16222320A phase I pharmacokinetic and pharmacodynamic study of BGC9331 and carboplatin in relapsed gynaecological malignancies.Br J Cancer2005https://conductscience.org/library/papers/16222320PubMed
15151521Population pharmacokinetics of total and unbound plasma cisplatin in adult patients.Br J Clin Pharmacol2004https://conductscience.org/library/papers/15151521PubMed
12556954Feasibility of combination chemotherapy with cisplatin and etoposide for haemodialysis patients with lung cancer.Br J Cancer2003https://conductscience.org/library/papers/12556954PubMed
11714450Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin.Jpn J Cancer Res2001https://conductscience.org/library/papers/11714450PubMed
10668856Oxaliplatin: pharmacokinetics and chronopharmacological aspects.Clin Pharmacokinet2000https://conductscience.org/library/papers/10668856PubMed
9376268Adjustment of creatinine clearance improves accuracy of Calvert's formula for carboplatin dosing.Br J Cancer1997https://conductscience.org/library/papers/9376268PubMed
8630273Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice.Br J Cancer1996https://conductscience.org/library/papers/8630273PubMed

See all 58 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/907657

GET https://conductscience.org/api/papers/v1/907657/cited_by?page=2